Allison S. Marquis

Allison Marquis practices at Clarity Dermatology in Castle Rock, Colorado.

Allison Marquis' NPI, 1124664248, was assigned on November 24, 2019. Allison Marquis holds Colorado license 0005807.

Allison Marquis' primary practice is Clarity Dermatology, at 4350 Limelight Ave, Castle Rock, CO 80109 in Douglas County. The practice phone is (720) 686-7546.

Allison Marquis' primary practice is Clarity Dermatology in Castle Rock, Colorado. The medical group on file is Clarity Dermatology. Dmand AI also links Allison Marquis to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Allison Marquis practices. Vendor and product names are available with a free account.

Dermatology is Allison Marquis' primary specialty in the NPI Registry, under taxonomy code 207N00000X. Allison Marquis is licensed in Colorado.

CMS data shows 1,467 Medicare services from Allison Marquis across 11 procedure codes in 2024, for 313 Medicare patients. Medicare paid $48,687 for them. Every service was in an office.

CMS counts 313 Medicare patients who saw Allison Marquis in 2024. The largest group is 65 to 74, with 186 patients. 75% of them have high cholesterol, and 57% have high blood pressure. Their average risk score is 0.76, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Allison Marquis' median patient age at 56, with 58% women.

In 2024, Allison Marquis wrote 165 Medicare Part D claims for 91 patients. 99% of them were for generic drugs. CMS names the drug for 112 of them, across 5 drugs with 11 or more claims each, at $2,545 in total drug cost. In 2023, CMS named 102 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Allison Marquis for performance year 2024, reported as part of a group. Allison Marquis accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 241 general payments to Allison Marquis from 28 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 92% of the total. Janssen Pharmaceuticals, Inc paid the most, $932.